Combat with Covid-19: Ukraine gets ready to sign deal with COVAX to get supplies

Source : 112 Ukraine

Healthcare Minister Stepanov says the vaccine will be arriving in Ukraine in several tranches; the first batch could total up to 1,200,000 doses
22:47, 19 November 2020

Ukraine gets ready to sign the deal on cooperation with COVAX company, so as to get access to anti-coronavirus vaccine supplies. The first batch could total up to 1,200,000 doses. Healthcare Minister Maksym Stepanov said so as quoted by the authority's press office.

"Technical requirement from Ukraine will be signed until November 27. The next step is a signature of conditions of cooperation until December 7", Stepanov said.

According to him, the vaccine will be arriving in Ukraine in several tranches. Stepanov added that medics will be the first patients to get the vaccine, as they are considered a priority risk group.

Related: About four million Ukrainians to get free access to Covid-19 vaccine in first half of 2021, - official

Up to 33,000 people could die from coronavirus in Ukraine by the end of the year. This is mentioned in the forecast of the Kyiv School of Economics (KSE). 

According to the paper, by January 2020, the number of victims in this country could make from 17,000 to 33,000 people. Everything depends on the quarantine scenario:

  • Green scenario: the most optimistic. It's the least likely scenario under current circumstances. 17,000 deaths might occur if the immediately imposed total lockdown works. 
  • Yellow scenario: 26,000 victims. That is possible if the weekend quarantine works. 
  • Black scenario: 33,000 victims. Possible if the lockdown does not work. 

The biggest load of beds in hospitals is possible in December 2020. KSE recommends expanding quarantine restrictions, currently known as weekend quarantine - up to the total lockdown.

Related: Oxford University vaccine shows high efficacy for elder age group

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more
latest news
editor's choice